Niki BioSolutions, Inc. (NIKI) vs XORTX Therapeutics Inc. (XRTX)
A side-by-side comparison of Niki BioSolutions, Inc. and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NIKI
Niki BioSolutions, Inc.
$4.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XRTX
XORTX Therapeutics Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NIKI vs XRTX
growth of $100 · dividends reinvested · last 8yNIKI -100.0% (-63.3%/yr)XRTX -97.8% (-37.8%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
NIKI XRTX
NIKI vs XRTX: by the numbers
- •XRTX is the larger company ($481786 vs $403887 market cap).
Metrics side by side
Valuation
| Metric | NIKI | XRTX |
|---|---|---|
| P/B ratio | 0.02 | 0.09 |
Profitability
| Metric | NIKI | XRTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -5.89% | -68.17% |
| ROIC | -10.38% | -71.43% |
Growth (annualized)
| Metric | NIKI | XRTX |
|---|---|---|
| Total return CAGR (5Y) | -71.40% | -63.52% |
Frequently asked
- How have NIKI and XRTX total returns compared?
- Over the past 5 years, NIKI delivered -71.40% and XRTX delivered -63.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.